Literature DB >> 6144956

Cyclosporin for Crohn's disease.

P A Bianchi, M Mondelli, F Quarto di Palo, T Ranzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6144956     DOI： 10.1016/s0140-6736(84)91728-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

2.  Oral administration of cyclosporin does not prevent expansion of antigen-specific, gut-associated, and spleen lymphocyte populations during Chlamydia trachomatis proctitis in nonhuman primates.

Authors:  M Zeitz; T C Quinn; A S Graeff; R Schwarting; S P James
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

3.  Effect of oral cyclosporin on renal function in Crohn's disease.

Authors:  A J Lobo; L D Juby; A H Smith; P N Foster; J Rothwell; J Pentith; T W Poole; A T Axon
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

4.  Effective intravenous cyclosporin therapy in a patient with severe Crohn's disease on parenteral nutrition.

Authors:  B F Allam; J E Tillman; T J Thomson; F T Crossling; L M Gilbert
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

5.  Cyclosporin A treatment in inflammatory bowel disease.

Authors:  E F Stange; W E Fleig; E Rehklau; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.